Cancers, Vol. 16, Pages 871: CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer
In conclusion, this study highlights that CA125 kinetics can serve as an early predictor for the progression of peritoneal metastasis during TAX/RAM treatment.
Source: Cancers - Category: Cancer & Oncology Authors: Akira Ueda Satoshi Yuki Takayuki Ando Ayumu Hosokawa Naokatsu Nakada Yosuke Kito Iori Motoo Ken Ito Miho Sakumura Yurika Nakayama Yuko Ueda Shinya Kajiura Koji Nakashima Kazuaki Harada Yasuyuki Kawamoto Yoshito Komatsu Ichiro Yasuda Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Carbohydrates | Chemotherapy | Gastric (Stomach) Cancer | Gastroenterology | Peritoneal Cancer | Study